Napo plans paediatric use of antidiarrhoeal compound
This article was originally published in Scrip
Executive Summary
Napo Pharmaceuticals says it will provide its novel antidiarrhoeal compound crofelemer to paediatric populations in disaster-affected and resource-constrained locations.